Shares of IsoRay, Inc. (NYSEAMERICAN:ISR) traded up 1.8% during trading on Wednesday . The company traded as high as $0.61 and last traded at $0.55. 7,590 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 686,247 shares. The stock had previously closed at $0.56.

Separately, HC Wainwright assumed coverage on IsoRay in a research note on Monday, August 20th. They issued a “neutral” rating and a $1.00 price target for the company.


IsoRay, Inc, through its subsidiary, IsoRay Medical, Inc, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma.

Read More: Risk Tolerance

Receive News & Ratings for IsoRay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IsoRay and related companies with's FREE daily email newsletter.